Advertisement

Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer

  • Dachang Ma
  • Cheng Chen
  • Jun Wu
  • Honglei Wang
  • Duoming Wu
Original Article

Abstract

Background

Long noncoding RNAs (lncRNAs) have been reported to play crucial roles in breast cancer. This study aimed to determine the clinical significance and biological functions of lncRNA AFAP1-AS1 in breast cancer.

Methods

The expression of AFAP1-AS1 in breast cancer tissue and adjacent normal tissue from 160 patients and breast cancer cell lines were determined by qRT-PCR. The clinical characteristics of patients were collected to analyse the correlation between AFAP1-AS1 expression and malignancy status. Kaplan–Meier and Cox proportional hazards model were used to analyze whether AFAP1-AS1 expression impacted prognosis. To assess the effect of AFAP1-AS1 on MCF-7 cells proliferation, cell viability, EdU incorporation and colony formation assays were conducted after AFAP1-AS1 knockdown by siRNA. The apoptosis was detected by Caspase-3 activity, cell cycle analysis, Bcl-2 and Bax protein expression. Wound scratch assay and EMT-related protein expression (E-cadherin, N-cadherin and Vimentin) were conducted to evaluate the metastasis ability. To further determine the effect of AFAP1-AS1 on AFAP1, the mRNA and protein expression of AFAP1 and subsequent actin filament integrity were measured after AFAP1-AS1 knockdown.

Results

The expression of AFAP1-AS1 was up-regulated in human breast cancer tissue and associated with malignancy status, high expression of AFAP1-AS1 had a poor prognosis in breast cancer patients. AFAP1-AS1 expression was up-regulated in 4 breast cancer cell lines (MCF-7, SK-RB-3, MDA-MB-231and MDA-MB-468) compared with normal breast cell line HBL-100. MCF-7, the most up-regulation cancer cell, was used for following studies. AFAP1-AS1 knockdown can inhibit the proliferation, metastasis and promote apoptosis of MCF-7. However, the AFAP1 expression and actin filament integrity was not affected after AFAP1-AS1 knockdown.

Conclusion

Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis in breast cancer patients and regulated the breast cancer cells proliferation, apoptosis and metastasis.

Keywords

Long non-coding RNA AFAP1-AS1 Breast cancer Proliferation Apoptosis Metastasis 

Notes

Compliance with ethical standards

Informed consent

All patients had signed the informed consent before surgery.

Ethics approval

Clinicopathological follow-up information from breast cancer patients was available. All clinical investigations in the present study were approved by the Human Ethics Committee in the First Hospital of Lanzhou University (Lanzhou, China) and conducted according to the principles expressed in Declaration of Helsinki.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Bartsch R, Bergen E. ASCO 2017: highlights in breast cancer. Memo. 2017;10:228–32.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Low SK, Zembutsu H, Nakamura Y. Breast cancer: the translation of big genomic data to cancer precision medicine. Cancer Sci. 2017;109:497CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Kumar M, DeVaux RS, Herschkowitz JI. Molecular and cellular changes in breast cancer and new roles of lncRNAs in breast cancer initiation and progression. Prog Mol Biol Transl Sci. 2016;144:563–86.CrossRefPubMedGoogle Scholar
  4. 4.
    Li RK, Gao J, Guo LH, Huang GQ, Luo WH. PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer. Cancer Gene Ther. 2017;24:309–15.CrossRefPubMedGoogle Scholar
  5. 5.
    Xu W, Chang J, Du X, Hou J. Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer. Biomed Pharmacother. 2017;95:1112–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Zheng Y, Song D, Xiao K, Yang C, Ding Y, Deng W, et al. LncRNA GAS5 contributes to lymphatic metastasis in colorectal cancer. Oncotarget. 2016;7:83727–34.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Hui H, Zhai Y, Ao L, Cleveland JC Jr, Liu H, Fullerton DA, et al. Klotho suppresses the inflammatory responses and ameliorates cardiac dysfunction in aging endotoxemic mice. Oncotarget. 2017;8:15663–76.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Liu FT, Xue QZ, Zhu PQ, Luo HL, Zhang Y, Hao T. Long noncoding RNA AFAP1-AS1, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis. Onco Targets Ther. 2016;9:4247–54.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Han X, Wang L, Ning Y, Li S, Wang Z. Long non-coding RNA AFAP1-AS1 facilitates tumor growth and promotes metastasis in colorectal cancer. Biol Res. 2016;49:36.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Ye Y, Chen J, Zhou Y, Fu Z, Zhou Q, Wang Y, et al. High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma. J Transl Med. 2015;13:137.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Deng J, Liang Y, Liu C, He S, Wang S. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients. Biomed Pharmacother. 2015;75:8–11.CrossRefPubMedGoogle Scholar
  12. 12.
    Bo H, Gong Z, Zhang W, Li X, Zeng Y, Liao Q, et al. Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma. Oncotarget. 2015;6:20404–18.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Yang F, Lyu S, Dong S, Liu Y, Zhang X, Wang O. Expression profile analysis of long noncoding RNA in HER-2-enriched subtype breast cancer by next-generation sequencing and bioinformatics. Onco Targets Ther. 2016;9:761–72.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403–10.CrossRefPubMedGoogle Scholar
  15. 15.
    Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med. 2010;134:e48–72.PubMedGoogle Scholar
  16. 16.
    Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med. 2007;131:18–43.PubMedGoogle Scholar
  17. 17.
    Li WQ, Li XH, Wu YH, Du J, Wang AP, Li D, et al. Role of eukaryotic translation initiation factors 3a in hypoxia-induced right ventricular remodeling of rats. Life Sci. 2016;144:61–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Lu X, Zhou C, Li R, Liang Z, Zhai W, Zhao L, et al. Critical role for the long non-coding RNA AFAP1-AS1 in the proliferation and metastasis of hepatocellular carcinoma. Tumour Biol. 2016;37:9699–707.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Wang F, Ni H, Sun F, Li M, Chen L. Overexpression of lncRNA AFAP1-AS1 correlates with poor prognosis and promotes tumorigenesis in colorectal cancer. Biomed Pharmacother. 2016;81:152–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Wang L, Cao J, Shi Z, Fan W, Liu H, Deng J, et al. Experimental study on the neurotoxic effect of beta-amyloid on the cytoskeleton of PC12 cells. Int J Mol Med. 2018;41:2764–70.PubMedPubMedCentralGoogle Scholar
  21. 21.
    Slaby O, Laga R, Sedlacek O. Therapeutic targeting of non-coding RNAs in cancer. Biochem J. 2017;474:4219–51.CrossRefPubMedGoogle Scholar
  22. 22.
    Giroud M, Scheideler M. Long non-coding RNAs in metabolic organs and energy homeostasis. Int J Mol Sci. 2017;18:2578CrossRefPubMedCentralGoogle Scholar
  23. 23.
    Xu N, Wang F, Lv M, Cheng L. Microarray expression profile analysis of long non-coding RNAs in human breast cancer: a study of Chinese women. Biomed Pharmacother. 2015;69:221–7.CrossRefPubMedGoogle Scholar
  24. 24.
    Shen X, Xie B, Ma Z, Yu W, Wang W, Xu D, et al. Identification of novel long non-coding RNAs in triple-negative breast cancer. Oncotarget. 2015;6:21730–9.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Zhang JY, Weng MZ, Song FB, Xu YG, Liu Q, Wu JY, et al. Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling. Int J Oncol. 2016;48:1590–8.CrossRefPubMedGoogle Scholar
  26. 26.
    Tang Y, He Y, Shi L, Yang L, Wang J, Lian Y, et al. Co-expression of AFAP1-AS1 and PD-1 predicts poor prognosis in nasopharyngeal carcinoma. Oncotarget. 2017;8:39001–11.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Zhou XL, Wang WW, Zhu WG, Yu CH, Tao GZ, Wu QQ, et al. High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Mol Carcinog. 2016;55:2095–105.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Guo JQ, Li SJ, Guo GX. Long Noncoding. RNA AFAP1-AS1 promotes cell proliferation and apoptosis of gastric cancer cells via PTEN/p-AKT pathway. Dig Dis Sci. 2017;62:2004–10.CrossRefPubMedGoogle Scholar
  29. 29.
    Baisden JM, Gatesman AS, Cherezova L, Jiang BH, Flynn DC. The intrinsic ability of AFAP-110 to alter actin filament integrity is linked with its ability to also activate cellular tyrosine kinases. Oncogene. 2001;20:6607–16.CrossRefPubMedGoogle Scholar
  30. 30.
    Cunnick JM, Kim S, Hadsell J, Collins S, Cerra C, Reiser P, et al. Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland. Oncogene. 2015;34:2640–9.CrossRefPubMedGoogle Scholar
  31. 31.
    Lv ZD, Kong B, Liu XP, Jin LY, Dong Q, Li FN, et al. miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer. J Cell Mol Med. 2016;20:864–73.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Wu W, Bhagat TD, Yang X, Song JH, Cheng Y, Agarwal R, et al. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology. 2013;144:956 e4–66 e4.Google Scholar
  33. 33.
    Zeng Z, Bo H, Gong Z, Lian Y, Li X, Li X, et al. AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis. Tumour Biol. 2016;37:729–37.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Breast Cancer Society 2018

Authors and Affiliations

  • Dachang Ma
    • 1
  • Cheng Chen
    • 1
  • Jun Wu
    • 1
  • Honglei Wang
    • 1
  • Duoming Wu
    • 1
  1. 1.Department of GalactophoreThe First Hospital of Lanzhou UniversityLanzhouPeople’s Republic of China

Personalised recommendations